1. Park C, Ha YC, Jang S, et al. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29:744–751.
Article
2. Salaffi F, Cimmino MA, Malavolta N, et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol. 2007; 34:1551–1560.
3. Yoon HK, Park C, Jang S, et al. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26:1087–1092.
Article
4. Lee YK, Jang S, Jang S, et al. Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int. 2012; 23:1859–1865.
5. Cranney A, Wells G, Willan A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev. 2002; 23:508–516.
Article
6. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med. 1998; 338:736–746.
Article
7. McClung MR. Therapy for fracture prevention. JAMA. 1999; 282:687–689.
Article
8. Watts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010; 16:Suppl 3. 1–37.
Article
9. Qaseem A, Snow V, Shekelle P, et al. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008; 149:404–415.
Article
10. Dawson-Hughes B. A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab. 2008; 93:2463–2465.
Article
11. Seeman E, Compston J, Adachi J, et al. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int. 2007; 18:711–719.
Article
12. Compston JE, Seeman E. Compliance with osteoporosis therapy is the weakest link. Lancet. 2006; 368:973–974.
Article
13. Gong HS, Oh WS, Chung MS, et al. Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. J Bone Joint Surg Am. 2009; 91:2376–2380.
Article
14. Choi HJ, Shin CS, Ha YC, et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab. 2012; 30:54–58.
Article
15. Kim SR, Ha YC, Park YG, et al. Orthopedic surgeon's awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study. J Korean Med Sci. 2011; 26:1501–1507.
Article
16. Zhang RF, Chandran M. Knowledge of osteoporosis and its related risk factors among nursing professionals. Singapore Med J. 2011; 52:158–162.
17. Wilson RK, Tomlinson G, Stas V, et al. Male and non-English-speaking patients with fracture have poorer knowledge of osteoporosis. J Bone Joint Surg Am. 2011; 93:766–774.
Article
18. Baek JH, Lee YK, Hong SW, et al. Knowledge on osteoporosis in guardians of hip fracture patients. J Bone Miner Metab. 2013; 31:481–484.
Article
19. Ailinger RL, Lasus H, Braun MA. Revision of the facts on osteoporosis quiz. Nurs Res. 2003; 52:198–201.
Article
20. Yoon BH, Baek JH, Lee YK, et al. Knowledge on osteoporosis of prescriber according to level of medical institute. Yonsei Med J. 2014; 55:1058–1062.
Article
21. Korea Women's Health and Osteoporosis Foundation. Korean Society of Osteoporosis. Korean Society of Gynecologic Endocrinology. Calcium and vitamin D recommendation. Seoul: Korea Women's Health and Osteoporosis Foundation;Korean Society of Osteoporosis;Korean Society of Gynecologic Endocrinology;2010.